- MaxCyte Inc (NASDAQ:MXCT) is already trading on London’s AIM, but now, it debuted on NASDAQ after pricing a $176 million IPO at $13 apiece, on the higher end of an $11.50 to $13.50 range.
- The Company offered 13.5 million shares during the IPO.
- MaxCyte’s technology uses electroporation, which applies an electric field to temporarily increase the permeability of the cell membrane and allow intracellular delivery of molecules, such as genetic material and proteins.
- The Company tagged $20 million – $30 million for R&D activities and another $20 million – $30 million to expand its manufacturing capabilities and invest in automation, according to the S-1/A.
- Price Action: MXCT opened at $16.99 and traded at $15.64 in the afternoon session.
Shiba Inu Developer Hints Major Update For Highly Anticipated Crypto Project Shibarium
Pseudonymous Shiba Inu (CRYPTO: SHIB) developer Shytoshi Kusama has hinted on the progress of the layer-2 project
